Journal List > J Korean Acad Nurs > v.48(6) > 1111062

Park, Chun, Jung, Bae, and Jung: Psychoeducational Approach to Distress Management of Newly Diagnosed Patients with Breast Cancer

Abstract

Purpose

The purpose of this study was to examine the effects of integrated psychoeducational program for distress management of newly diagnosed patients with breast cancer.

Methods

A quasi-experimental trial was conducted. The participants consisted of 47 female patients with breast cancer assigned to an intervention group (n=25) and control group (n=22). The intervention group participated in integrated psychoeducational program, consisting of individual face-to-face education and telephone-delivered health-coaching sessions. Data were collected at three time points: pre-intervention (T1), post-intervention (T2), and 6-month follow-up (T3). Study instruments were Distress thermometer, Supportive Care Needs Survey Short Form 34 and Functional Assessment of Cancer Therapy-Breast.

Results

Compared with the control group, breast cancer patients in the intervention group reported lower distress and supportive care needs than the control group. The intervention group reported higher quality of life (QOL) overall and higher emotional well-being than the control group.

Conclusion

These findings indicate that the integrated psychoeducational program is an effective intervention for reducing distress and supportive care needs and increasing QOL of newly diagnosed patients with breast cancer. Oncology nurses need to provide psychoeducational intervention to support patients with breast cancer in managing their distress and helping them adjust to their life.

References

1. Korean Breast Cancer Society. Breast cancer facts & figures 2018 [Internet]. Seoul: Korean Breast Cancer Society;c2018. [cited 2018 Nov 01]. Available from:. http://www.kbcs.or.kr/journal/file/181030.pdf.
2. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, et al. American Cancer Society/Ameri-can Society of clinical oncology breast cancer survivorship care guideline. CA: A Cancer Journal for Clinicians. 2016; 66(1):43–73. https://doi.org/10.3322/caac.21319.
crossref
3. Syrowatka A, Motulsky A, Kurteva S, Hanley JA, Dixon WG, Meguerditchian AN, et al. Predictors of distress in female breast cancer survivors: A systematic review. Breast Cancer Research and Treatment. 2017; 165(2):229–245. https://doi.org/10.1007/s10549-017-4290-9.
crossref
4. Holland JC, Andersen B, Breitbart WS, Buchmann LO, Com-pas B, Deshields TL, et al. Distress management. Journal of the National Comprehensive Cancer Network. 2013; 11(2):190–209. https://doi.org/10.6004/jnccn.2013.0027.
crossref
5. Liao MN, Chen SC, Chen SC, Lin YC, Chen MF, Wang CH, et al. Change and predictors of symptom distress in breast cancer patients following the first 4 months after diagnosis. Journal of the Formosan Medical Association. 2015; 114(3):246–253. https://doi.org/10.1016/j.jfma.2013.06.009.
crossref
6. Park JH, Chun M, Jung YS, Bae SH. Predictors of psychological distress trajectories in the first year after a breast cancer diagnosis. Asian Nursing Research. 2017; 11(4):268–275. https://doi.org/10.1016/j.anr.2017.10.003.
crossref
7. Liao MN, Chen SC, Chen SC, Lin YC, Hsu YH, Hung HC, et al. Changes and predictors of unmet supportive care needs in Taiwanese women with newly diagnosed breast cancer. Oncology Nursing Forum. 2012; 39(5):E380–E389. https://doi.org/10.1188/12.onf.e380-e389.
crossref
8. Fiszer C, Dolbeault S, Sultan S, Brédart A. Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: A systematic review. Psycho-Oncology. 2014; 23(4):361–374. https://doi.org/10.1002/pon.3432.
crossref
9. Park JH, Chun M, Jung YS, Jung YM. Changes of supportive care needs and quality of life in patients with breast cancer. Asian Oncology Nursing. 2016; 16(4):217–225. https://doi.org/10.5388/aon.2016.16.4.217.
crossref
10. Fagerlind H, Kettis Å, Glimelius B, Ring L. Barriers against psychosocial communication: Oncologists’ perceptions. Journal of Clinical Oncology. 2013; 31(30):3815–3822. https://doi.org/10.1200/jco.2012.45.1609.
crossref
11. Barsevick AM, Sweeney C, Haney E, Chung E. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncology Nursing Forum. 2002; 29(1):73–87. https://doi.org/10.1188/02.onf.73-87.
crossref
12. D’Egidio V, Sestili C, Mancino M, Sciarra I, Cocchiara R, Backhaus I, et al. Counseling interventions delivered in women with breast cancer to improve health-related quality of life: A systematic review. Quality of Life Research. 2017; 26(10):2573–2592. https://doi.org/10.1007/s11136-017-1613-6.
crossref
13. Matsuda A, Yamaoka K, Tango T, Matsuda T, Nishimoto H. Effectiveness of psychoeducational support on quality of life in early-stage breast cancer patients: A systematic review and meta-analysis of randomized controlled trials. Quality of Life Research. 2014; 23(1):21–30. https://doi.org/10.1007/s11136-013-0460-3.
crossref
14. Milanti A, Metsälä E, Hannula L. Reducing psychological distress in patients undergoing chemotherapy. British Journal of Nursing. 2016; 25(4):S25–S30. https://doi.org/10.12968/bjon.2016.25.4.s25.
crossref
15. Schulman-Green D, Jeon S. Managing cancer care: A psycho‐ educational intervention to improve knowledge of care options and breast cancer self‐management. Psycho-Oncology. 2017; 26(2):173–181. https://doi.org/10.1002/pon.4013.
16. Wu PH, Chen SW, Huang WT, Chang SC, Hsu MC. Effects of a psychoeducational intervention in patients with breast cancer undergoing chemotherapy. Journal of Nursing Research. 2018; 26(4):266–279. https://doi.org/10.1097/jnr.0000000000000252.
crossref
17. Ashing KT, Miller AM. Assessing the utility of a telephonically delivered psychoeducational intervention to improve health-related quality of life in African American breast cancer survivors: A pilot trial. Psycho-Oncology. 2016; 25(2):236–238. https://doi.org/10.1002/pon.3823.
crossref
18. Dastan NB, Buzlu S. Psychoeducation intervention to improve adjustment to cancer among Turkish stage I-II breast cancer patients: A randomized controlled trial. Asian Pacific Journal of Cancer Prevention. 2012; 13(10):5313–5318. https://doi.org/10.7314/apjcp.2012.13.10.5313.
crossref
19. van den Berg SW, Gielissen MFM, Ottevanger PB, Prins JB. Rationale of the BREAst cancer e-healTH [BREATH] multicentre randomised controlled trial: An internet-based self-management intervention to foster adjustment after curative breast cancer by decreasing distress and increasing empowerment. BMC Cancer. 2012; 12:394. https://doi.org/10.1186/1471-2407-12-394.
crossref
20. Mens MG, Helgeson VS, Lembersky BC, Baum A, Scheier MF. Randomized psychosocial interventions for breast cancer: Impact on life purpose. Psycho-Oncology. 2016; 25(6):618–625. https://doi.org/10.1002/pon.3891.
crossref
21. Lee KS, Lee R, Kim DM, Kim SH. The effects of a comprehensive education program on knowledge, self-efficacy, and coping style among newly diagnosed patients with breast cancer. Asian Oncology Nursing. 2012; 12(1):35–43. https://doi.org/10.5388/aon.2012.12.1.35.
crossref
22. Ok ON, Nam MS, Yi MS, Cho SM, Kim EJ, Ham YH, et al. Effects of telephone counseling support on distress, anxiety, depression, and adverse events in cancer patients receiving chemotherapy. Asian Oncology Nursing. 2017; 17(1):37–44. https://doi.org/10.5388/aon.2017.17.1.37.
crossref
23. National Comprehensive Cancer Network. Distress thermometer screening tool figure (DIS-A), V.2.2013 [Internet]. Plymouth Meeting (PA): National Comprehensive Cancer Network;c2013. [cited 2013 Jun 2]. Available from:. https://www.nccn.org/global/international_adaptations.aspx.
24. Boyes A, Girgis A, Lecathelinais C. Brief assessment of adult cancer patients’ perceived needs: Development and validation of the 34‐item Supportive Care Needs Survey (SCNS-SF34). Journal of Evaluation in Clinical Practice. 2009; 15(4):602–606. https://doi.org/10.1111/j.1365-2753.2008.01057.x.
crossref
25. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. Journal of Clinical Oncology. 1997; 15(3):974–986. https://doi.org/10.1200/jco.1997.15.3.974.
crossref
26. Yoo HJ, Ahn SH, Eremenco S, Kim H, Kim WK, Kim SB, et al. Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4. Quality of Life Research. 2005; 14(6):1627–1632. https://doi.org/10.1007/s11136-004-7712-1.
crossref
27. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates;1988. p. 19–66.
28. Schofield P, Ugalde A, Gough K, Reece J, Krishnasamy M, Carey M, et al. A tailored, supportive care intervention using systematic assessment designed for people with inoperable lung cancer: A randomised controlled trial. Psycho-Oncology. 2013; 22(11):2445–2453. https://doi.org/10.1002/pon.3306.
crossref
29. White VM, Macvean ML, Grogan S, D’Este C, Akkerman D, Ieropoli S, et al. Can a tailored telephone intervention delivered by volunteers reduce the supportive care needs, anxiety and depression of people with colorectal cancer? A randomised controlled trial. Psycho-Oncology. 2012; 21(10):1053–1062. https://doi.org/10.1002/pon.2019.
crossref
30. Ai ZP, Gao XL, Li JF, Zhou JR, Wu YF. Changing trends and influencing factors of the quality of life of chemotherapy patients with breast cancer. Chinese Nursing Research. 2017; 4(1):18–23. https://doi.org/10.1016/j.cnre.2017.03.006.
crossref

Table 1.
Homogeneity Test of Demographic and Clinical Characteristics between Two Groups
Variables Categories Exp. (n=25) Cont. (n=22) χ2 p
n (%) n (%)
Age (yr) <40 5 (45.5) 6 (54.5) 1.51 .471
40~49 13 (50.0) 13 (50.0)
≥50 7 (70.0) 3 (30.0)
Educational level ≤High school 13 (46.4) 15 (53.6) 0.37 .204
≥University 12 (63.2) 7 (36.8)
Marital status Single 4 (50.0) 4 (50.0) 0.34 .573
Married 21 (53.8) 18 (46.2)
Occupation No 6 (35.3) 11 (64.7) 0.08 .061
Yes 19 (63.3) 11 (36.7)
Cancer stage I 13 (65.0) 7 (35.0) 2.62 .270
II 10 (41.7) 14 (58.3)
III 2 (66.7) 1 (33.3)
Method of surgery Partial mastectomy 23 (51.1) 22 (48.9) - .278
Total mastectomy 2 (100.0) 0 (0.0)
Chemotherapy No 9 (75.0) 3 (25.0) 3.08 .077
Yes 16 (45.7) 19 (54.3)
Hormonal therapy No 4 (57.1) 3 (42.9) - .574
Yes 21 (52.5) 19 (47.5)
Target therapy No 23 (51.1) 22 (48.9) - .278
Yes 2 (100.0) 0 (0.0)

Exp.=Experimental group; Cont.=Control group.

Fisher’s exact test.

Table 2.
Homogeneity Tests of Dependent Variables between Two Groups
Variable Exp. (n=25) Cont. (n=22) t or z p
M±SD M±SD
Distress 5.40±3.03 4.63±2.26 -0.99 .329
Supportive care needs
  Psychological needs 53.30±29.84 47.16±22.66 -0.78 .436
  Health system and information needs 50.09±31.92 49.79±27.94 -0.14 .890
  Physical and daily living needs 18.60±21.91 30.91±23.89 -1.96 .051
  Patient care and supportive needs 27.00±17.91 31.36±28.54 -0.10 .923
  Sexuality needs 14.67±17.39 15.01±24.52 -0.29 .773
Quality of life 96.85±15.15 96.51±14.77 -0.24 .814
  Physical well-being Social/family well-being 23.60±3.25 21.96±4.72 -1.43 .159
  Social/family well-being 17.89±5.54 17.23±5.96 -0.44 .662
  Emotional well-being 14.52±5.84 17.24±3.35 -1.42 .155
  Functional well-being 17.44±4.32 15.84±4.09 -1.59 .120
  Breast cancer-specific subscale 23.36±4.51 24.28±4.07 0.01 .998

Exp.=Experimental group; Cont.=Control group; M=Mean; SD=standard deviation.

Mann-Whitney U test.

Table 3.
Comparison of Distress and Quality of Life between Two Groups
Variable Group Time Difference Difference Cohen’s d
T1 T2 T3 Source F (p) (T2-T1) (T3-T1) Exp.~Cont.
M±SD M±SD M±SD M±SD t (p) M±SD t (p) T2 T3 T3
Distress Exp. (n=25) 5.40±3.03 2.52±1.69 1.88±1.54 Group 0.95 (.336) -2.88±2.71 -2.94 (.005) -3.52±3.64 -1.32 (.195) 0.84 0.37
Time 28.06 (<.001)
Cont. (n=22) 4.63±2.26 4.13±2.23 2.27±1.66 Group×Time 4.56 (.017) -0.50±2.84 -2.36±2.30
Quality of life Exp. (n=25) 96.85±16.14 99.79±8.90 102.11±7.74 Group 9.86 (.003) 2.94±17.60 2.69 (.010) 5.26±15.70 2.28 (.027) 0.77 0.66
Time 2.30 (.125)
Cont. (n=22) 95.70±12.15 86.92±9.49 91.95±11.41 Group×Time 5.74 (.011) -8.79±11.10 -3.76±10.52
Physical well-being Exp. (n=25) 23.60±3.25 21.32±2.81 22.04±3.02 Group 5.00 (.030) -2.28±4.00 1.20 (.235) -1.56±2.10 -0.33 (.740) 0.35 0.10
Time 11.51 (<.001)
Cont. (n=22) 22.27±4.17 18.31±3.78 21.18±4.94 Group×Time 1.49 (.230) -3.95±5.49 -1.09±5.50
Social/family well-being Exp. (n=25) 17.89±5.54 18.27±2.37 18.55±2.47 Group 2.81 (.101) 0.38±5.95 0.56 (.582) 0.66±6.15 1.12 (.269) 0.16 0.32
Time 0.05 (.900)
Cont. (n=22) 17.20±5.00 16.73±3.89 16.12±4.56 Group×Time 0.82 (.408) -0.47±4.30 -1.08±4.13
Emotional well-being Exp. (n=25) 14.52±5.84 18.32±2.90 19.60±2.16 Group 0.15 (.702) 3.80±7.11 2.47 (.019) 5.08±6.56 3.13 (.003) 0.68 0.87
Time 7.67 (.003)
Cont. (n=22) 17.18±2.97 17.09±3.02 17.45±2.44 Group×Time 6.65 (.003) -0.09±3.16 0.27±3.73
Functional well-being Exp. (n=25) 17.44±4.32 18.00±3.71 18.28±3.48 Group 4.68 (.036) 0.56±6.21 0.26 (.800) 0.84±5.84 -0.11 (.910) 0.07 0.03
Time 1.05 (.340)
Cont. (n=22) 15.77±2.79 15.95±3.98 16.77±3.89 Group×Time 0.09 (.860) 0.18±3.30 1.00±3.27
Breast cancer-specific subscale Exp. (n=25) 23.36±4.51 23.24±4.32 23.28±4.39 Group 5.00 (.030) -0.12±5.13 3.02 (.004) -0.08±4.57 2.05 (.047) 0.87 0.59
Time 6.81 (.004)
Cont. (n=22) 23.36±3.30 19.05±4.46 20.55±4.50 Group×Time 6.09 (.006) -4.32±4.29 -2.82±4.58

Exp.=Experimental group; Cont.=Control group; T1=Before intervention; T2=Immediately after intervention; T3=6 months after the end of intervention; M=Mean; SD=standard deviation.

Table 4.
Comparison of Supportive Care Needs between Two Groups
Variables Group Time Difference Difference (T3-T1)
T1 T2 T3 χ2 (p) (T2-T1)
M±SD M±SD M±SD M±SD z (p) M±SD z (p)
Psychological needs Exp. (n=25) 53.30±29.84 38.50±20.67 32.20±20.02 15.90 (<.001) -14.80±33.20 -2.72 -21.10±27.76 -1.46
Cont. (n=22) 47.16±22.66 58.07±16.61 37.73±21.90 8.81 (.012) 10.91±29.12 (.007) -9.43±31.21 (.144)
Health system and information needs Exp. (n=25) 50.09±31.92 28.91±14.44 26.82±19.06 8.83 (.013) -21.18±35.27 -2.68 -23.27±31.67 -0.65
Cont. (n=22) 49.79±27.94 61.47±19.14 36.67±26.16 9.39 (.009) 11.67±37.92 (.007) -13.12±36.32 (.515)
Physical and daily living needs Exp. (n=25) 18.60±21.91 29.00±19.03 17.20±17.44 6.61 (.037) 10.40±27.00 -1.21 -1.40±26.91 -0.24
Cont. (n=22) 30.91±23.89 52.50±27.80 30.22±21.95 9.02 (.011) 21.59±34.38 (.227) -0.68±23.11 (.814)
Patient care and supportive needs Exp. (n=25) 27.00±17.91 21.60±19.24 15.20±13.27 5.58 (.058) -5.40±30.55 -1.95 -11.80±23.80 -1.93
Cont. (n=22) 31.36±28.54 43.41±26.33 30.91±26.89 6.79 (.034) 12.05±40.26 (.052) -0.45±36.48 (.054)
Sexuality needs Exp. (n=25) 14.67±17.39 19.33±23.78 15.00±19.39 0.27 (.873) 4.67±22.45 -3.28 0.33±24.71 -0.02
Cont. (n=22) 15.01±24.52 48.86±25.76 14.02±22.48 19.92 (<.001) 32.95±30.59 (.001) -1.89±28.86 (.982)

Exp.=Experimental group; Cont.=Control group; T1=Before intervention; T2=Immediately after intervention; T3=6 months after the end of intervention; M=Mean; SD=standard deviation.

Mann-Whitney U test.

TOOLS
Similar articles